| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 81451 |
DiR Labeled Mannosylated Control Liposome (Neutral),DiR标记的甘露糖对照脂质体(中性) |
181 |
axc |
2024-12-24 |
| 81452 |
Bromo-PEG5-CH2COOtBu |
164 |
h |
2024-12-24 |
| 81453 |
DiD Labeled Mannosylated Control Liposome (Neutral),标记的甘露糖对照脂质体(中性) |
254 |
axc |
2024-12-24 |
| 81454 |
Bromo-PEG8-CH2COOtBu |
124 |
h |
2024-12-24 |
| 81455 |
DiA Labeled Mannosylated Control Liposome (Neutral),DiA标记的甘露糖对照脂质体(中性) |
155 |
axc |
2024-12-24 |
| 81456 |
Biotin-PEG3-CH2COOH,CAS号：1189560-96-0,生物素-PEG3-乙酸 |
228 |
h |
2024-12-24 |
| 81457 |
DiI Labeled Mannosylated Control Liposome (Neutral),DiI标记的甘露糖对照脂质体(中性) |
139 |
axc |
2024-12-24 |
| 81458 |
HO-PEG5-CH2COOH,CAS号：52026-48-9 |
127 |
h |
2024-12-24 |
| 81459 |
DiR Labeled Control Clodronate Liposome (Neutral),DiR标记的对照氯膦酸盐脂质体(中性) |
174 |
axc |
2024-12-24 |
| 81460 |
BocNH-PEG4-CH2CHO |
146 |
h |
2024-12-24 |
| 81461 |
DiD Labeled Control Clodronate Liposome (Neutral),DiD标记的对照氯膦酸盐脂质体(中性) |
163 |
axc |
2024-12-24 |
| 81462 |
m-PEG1000-CH2COOH |
182 |
h |
2024-12-24 |
| 81463 |
Benzyl-PEG2-CH2COOH,CAS号：91842-53-4 |
161 |
h |
2024-12-24 |
| 81464 |
DiA Labeled Control Clodronate Liposome (Neutral),DiA标记的对照氯膦酸盐脂质体(中性) |
148 |
axc |
2024-12-24 |
| 81465 |
Propanol-PEG6-CH2OH |
140 |
h |
2024-12-24 |
| 81466 |
DiI Labeled Control Clodronate Liposome (Neutral),DiI标记的对照氯膦酸盐脂质体(中性) |
154 |
axc |
2024-12-24 |
| 81467 |
Mannosylated Control Liposome,甘露糖对照脂质体 |
198 |
axc |
2024-12-24 |
| 81468 |
Propanol-PEG4-CH2OH,CAS号：156868-17-6 |
156 |
h |
2024-12-24 |
| 81469 |
Propanol-PEG3-CH2OH,CAS号：112935-57-6 |
140 |
h |
2024-12-24 |
| 81470 |
Mannosylated Clodronate Liposome,甘露糖基氯膦酸盐脂质体 |
263 |
axc |
2024-12-24 |
| 81471 |
Fmoc-Val-Cit-PAB，159858-22-7，抗体- 药物偶联物 |
162 |
zhn |
2024-12-24 |
| 81472 |
Propanol-PEG5-CH2OH |
124 |
h |
2024-12-24 |
| 81473 |
Control Liposome,对照脂质体 |
153 |
axc |
2024-12-24 |
| 81474 |
HO-PEG10-CH2COOH,CAS号：2250056-53-0 |
195 |
h |
2024-12-24 |
| 81475 |
Clodronate Liposome,氯膦酸盐脂质体 |
427 |
axc |
2024-12-24 |
| 81476 |
HO-PEG6-CH2COOH,CAS号：120394-66-3具体解释和潜在应用 |
253 |
h |
2024-12-24 |
| 81477 |
Amino-PEG11-CH2COOH具体解释和潜在应用 |
124 |
h |
2024-12-24 |
| 81478 |
0.5% Rhod-PE Encapsulated GL67:DOPE Liposomes,阳离子脂质体定制服务 |
188 |
axc |
2024-12-24 |
| 81479 |
Fmoc-Val-Cit-PAB，159858-22-7， 抗体- 药物偶联物 |
144 |
zhn |
2024-12-24 |
| 81480 |
HO-PEG24-CH2COOH具体解释和潜在应用 |
118 |
h |
2024-12-24 |
| 81481 |
0.5% NBD-DOPE Encapsulated GL67:DOPE Liposomes,0.5% NBD-DOPE封装的GL67:DOPE脂质体 |
143 |
axc |
2024-12-24 |
| 81482 |
m-PEG10-CH2COOH,CAS号：908258-58-2,十一氧杂三十四烷酸 |
140 |
h |
2024-12-24 |
| 81483 |
HO-PEG8-CH2COOH,CAS号：780006-30-6 |
175 |
h |
2024-12-24 |
| 81484 |
GL67:DOPE Liposomes,GL67与DOPE组成的脂质体 |
183 |
axc |
2024-12-24 |
| 81485 |
0.5% Rhod-PE Encapsulated DC-Chol:DOPE Liposomes,0.5% Rhod-PE封装的DC-Chol:DOPE脂质体 |
214 |
axc |
2024-12-24 |
| 81486 |
m-PEG9-CH2COOH,CAS号：405518-55-0 |
148 |
h |
2024-12-24 |
| 81487 |
Tos-PEG5-CH2COOtBu,CAS号：1949793-62-7 |
140 |
h |
2024-12-24 |
| 81488 |
0.5% NBD-DOPE Encapsulated DC-Chol:DOPE Liposomes,0.5% NBD-DOPE封装的DC-Chol:DOPE脂质体 |
462 |
axc |
2024-12-24 |
| 81489 |
Hydroxy-PEG4-CH2COOH,14-羟基-3,6,9,12-四氧杂癸酸,CAS号：70678-95-4 |
153 |
h |
2024-12-24 |
| 81490 |
DC-Chol:DOPE Liposomes,DC-Chol与DOPE组成的脂质体 |
369 |
axc |
2024-12-24 |
| 81491 |
Hydroxy-PEG2-CH2COOH,CAS号：51951-04-3 |
114 |
h |
2024-12-24 |
| 81492 |
0.5% Rhod-PE Encapsulated DOTMA:DOPE Liposomes,0.5% Rhod-PE包裹的DOTMA:DOPE脂质体 |
212 |
axc |
2024-12-24 |
| 81493 |
Tos-PEG3-CH2COOH,CAS号：1581248-63-6 |
125 |
h |
2024-12-24 |
| 81494 |
m-PEG4-CH2COOH,CAS号：16024-66-1 |
138 |
h |
2024-12-24 |
| 81495 |
0.5% NBD-DOPE Encapsulated DOTMA:Chol Liposomes,阳离子脂质体定制服务 |
166 |
axc |
2024-12-24 |
齐岳微信公众号
官方微信
库存查询